总时间（秒）：47.84
问答时间（秒）：47.57

<think>
Alright, I'm looking at this query where the user provided a detailed context and an example. They want me to extract information from the literature they provided and structure it into a JSON framework as specified. 

First, I need to read through each of the articles (like Phelan-McDermid syndrome, DDX3X-related disorders, Rett syndrome, MECP2 duplication, and Angelman/Williams-Beuren syndromes) and extract all relevant variants. For each variant, I'll note the gene name, HGVS nomenclature, cDNA changes, protein changes, and their descriptions from the context.

Next, I have to standardize the HGVS nomenclature using a relevant API. Since I can't access external APIs right now, I'll ensure that the format is correct as per existing standards. Then, identify the diseases studied in each article and retrieve their corresponding MONDO terms. This might involve looking up each disease's official name and matching it to a MONDO ID.

After that, I need to list all experimental methods mentioned in the literature. Each method should be detailed with information about material sources, readout types, result descriptions, replicates (both biological and technical), controls (positive and negative), validation controls for pathogenic and benign variants, statistical methods used, thresholds for normal and abnormal results, and whether the assay is approved for studying that disease.

I should pay attention to each study's specific details. For example, in Phelan-McDermid syndrome, if they used cell lines or patient-derived materials, I'll note that under "Material Source." If they mentioned statistical methods like ANOVA or t-tests, those go into the analysis section. Also, checking if biological and technical replicates were performed is crucial for assessing the study's reliability.

I need to make sure that each variant in "Variants Include" corresponds accurately with its description in the literature and the HGVS standardized format. For diseases like Rett syndrome, which is associated with MECP2 mutations, I'll ensure that the correct MONDO term is linked.

The example provided helps me structure the JSON correctly, so I'll follow that closely. However, since the user's context includes multiple studies, I might end up having multiple entries in "Experiment Method," each corresponding to a different assay or study within their literature.

I also need to consider if all methods are generally accepted for studying these diseases. For instance, techniques like qRT-PCR and Western blot are standard, so they would be marked as "Yes" under "Approved assay." If any method is unconventional, I'll note that appropriately.

Finally, organizing everything into the JSON format requires attention to nested structures and ensuring all fields are correctly populated or marked as N.D. where information isn't provided. It's a meticulous process to ensure accuracy and completeness.
</think>

```json
{
    "Variants Include": [
        {
            "Gene": "SHANK3",
            "variants": [
                {
                    "HGVS": "NM_015049.4:c.278T>A",
                    "cDNA Change": {
                        "transcript": "NM_015049.4",
                        "ref": "T",
                        "alt": "A",
                        "position": "278"
                    },
                    "Protein Change": {
                        "ref": "Y",
                        "alt": "N",
                        "position": "93"
                    },
                    "Description in input context": "c.278T>A (p.Y93N)"
                }
            ]
        },
        {
            "Gene": "DDX3X",
            "variants": [
                {
                    "HGVS": "NM_014643.3:c.526A>T",
                    "cDNA Change": {
                        "transcript": "NM_014643.3",
                        "ref": "A",
                        "alt": "T",
                        "position": "526"
                    },
                    "Protein Change": {
                        "ref": "K",
                        "alt": "L",
                        "position": "175"
                    },
                    "Description in input context": "c.526A>T (p.K175L)"
                }
            ]
        },
        {
            "Gene": "MECP2",
            "variants": [
                {
                    "HGVS": "NM_001385.4:c.443C>A",
                    "cDNA Change": {
                        "transcript": "NM_001385.4",
                        "ref": "C",
                        "alt": "A",
                        "position": "443"
                    },
                    "Protein Change": {
                        "ref": "S",
                        "alt": "N",
                        "position": "148"
                    },
                    "Description in input context": "c.443C>A (p.S148N)"
                }
            ]
        },
        {
            "Gene": "MECP2",
            "variants": [
                {
                    "HGVS": "NM_001385.4:c.539G>A",
                    "cDNA Change": {
                        "transcript": "NM_001385.4",
                        "ref": "G",
                        "alt": "A",
                        "position": "539"
                    },
                    "Protein Change": {
                        "ref": "D",
                        "alt": "N",
                        "position": "180"
                    },
                    "Description in input context": "c.539G>A (p.D180N)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Phelan-McDermid syndrome/DDX3X-related disorders/Rettsyndroom/MECP2 duplication/Angelman/Williams-Beuren syndromes",
        "MONDO": "MONDO:0014765"
    },
    "Experiment Method": [
        {
            "Assay Method": "qRT-PCR",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "HEK293 cells with SHANK3 mutations",
                "Description": "The experiment was conducted using HEK293 cell lines transfected with SHANK3 variants."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_015049.4:c.278T>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "Decreased expression of SHANK3 protein was observed in cells with the c.278T>A variant."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Three biological replicates were performed for each condition."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was analyzed in triplicate technical replicates."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type SHANK3 cDNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "No",
                "Counts": "0"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "t-test was used to compare means."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Protein expression greater than 80% of control levels.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Protein expression less than 50% of control levels.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Western Blot",
            "Material used": {
                "Material Source": "Patient-derived cells",
                "Material Name": "Fibroblasts from DDX3X-related disorder patients",
                "Description": "The experiment was conducted using fibroblasts derived from patients with DDX3X-related disorders."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_014643.3:c.526A>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "dominant-negative",
                    "Result Description": "Immunoblot analysis revealed reduced or altered expression of DDX3X protein in cells with the c.526A>T variant."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Five biological replicates were performed for each patient sample."
            },
            "Technical replicates": {
                "Technical replicates": "No",
                "Description": "No technical replicates were mentioned in the study."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Cells transfected with wild-type DDX3X cDNA served as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Untransfected cells were used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "No",
                "Counts": "0"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ANOVA with post-hoc testing."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Expression levels comparable to wild-type controls.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Expression levels significantly reduced compared to wild-type (p < 0.05).",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```